Clinical Trials Research Unit, Centre for Eye Research Australia
A/Prof Lyndell Lim, a Uveitis and Medical Retina Subspecialist, leads the Clinical Trials Research Unit at the Centre for Eye Research Australia. A/Prof Lim is largely involved in clinical studies, particularly in the field of uveitis and ocular immunology, and diabetic retinopathy. Her team runs both investigator initiated and sponsored clinical trials that aim to investigate new treatments in a variety of ophthalmic diseases.
Current projects include prospective randomised clinical trials in diabetic macular oedema, the major cause of visual loss in diabetic retinopathy, and chronic non-infectious uveitis, a form of blinding auto-immune disease of the eye.
Other Clinical Investigators within the Unit include Dr Sanjeewa Wickremasighe and Dr Suki Sandhu who are both Medical Retina Subspecialists. Their research focus is also in clinical ophthalmology in the fields of diabetic retinopathy and retinal vascular diseases.
Sanj Wickremasinghe, Clinical Investigator
Sukhi Sandhu, Clinical Investigator
Helen Ormandy, Clinical Trials Unit Manager
Kelly Mikunda, Executive Assistant
Carly Parfett, Senior Study Coordinator
Tanya Pejnovic, Senior Study Coordinator
Jessica Brennan, Study Coordinator
Roberta Cimetta, Research Assistant
Maria Kolic, Study Coorindator
Thuy Chau, Study Coordinator
Sutha Sanmugasundram, Study Coordinator
Marios Constantinou, Senior Study Coordinator
Julie Morrison, Senior Study Coordinator & Training Manager
Kiera Young, Study Coordinator
Theona Nicolau, Study Coordinator
Lauren Hodgson, Retinal Image Grading Centre Manager
Jessica Alessi-Calandro, Retinal Image Grader
Elizabeth Alesandrello, Retinal Image Grader
Professor Mark Gillies, Save Sight Institute/Sydney Eye Hospital, Sydney, NSW
A/Professor Samantha Fraser-Bell, Save Sight Institute/Sydney Eye Hospital, Sydney, NSW
Professor Peter McCluskey, Save Sight Institute/Sydney Eye Hospital, Sydney, NSW
Professor Doug Jabs, Mount Sinai Medical Center, New York, USA
Dr Nisha Acharaya, University of California San Francisco, California, USA
Dr James T Rosenbaum, Casey Eye Institute, Portland, Oregon, USA
Dr Friederike Mackensen, Heidelberg University, Heidelberg, Germany
Dr John Kempen, University of Pennsylvania, USA
Professor Ian Wicks, WEHI
A/Professor Anthony Hall, Alfred Hospital, Victoria
A/Professor Andrew Symons, Royal Melbourne Hospital, Victoria
NHMRC Early Career Fellowship
Sponsored Drug trials (Bayer, Allergan etc).
This research project is available to PhD students to join as part of their thesis.
Please contact the Research Group Leader to discuss your options.
1.Gillies MC, Lim LL, Campain A, Quin GJ, Salem W, Li J, Goodwin S, Aroney C, McAllister IL & Fraser-Bell S. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study. Ophthalmology 2014;121(12):2473-81.
2.Suhler EB, Lim LL, Beardsley RM, Giles TR, Pasadhika S, Lee ST, de Saint Sardos A, Butler NJ, Smith JR & Rosenbaum JT. Rituximab Therapy for Refractory Scleritis: Results of a Phase I/II Dose-Ranging, Randomized, Clinical Trial. Ophthalmology 2014;121(10):1885-91.
3.Chiam NP, Hall AJ, Stawell RJ, Busiya L & Lim LL. The course of uveitis in pregnancy and postpartum. Br J Ophthalmol 2013;97:1284-1288.
4.Fenwick E, Lamoureux EL, Finger RP, Lim LL & Rees G. Patients’ causal beliefs about diabetic retinopathy. Optom Vis Sci. 2013; 90(8):874-882.
5.Fraser-Bell S, Lim LL, Campain A, Mehta H, Aroney C, Bryant J, Li J, Quin GJ, McAllister IL, Gillies MC. Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study). Ophthalmology 2016 Jan 9. [Epub ahead of print].